SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-18-000035
Filing Date
2018-11-14
Accepted
2018-11-14 16:41:27
Documents
65
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sls-20180930x10q.htm 10-Q 936984
2 EXHIBIT 31.1 sls20180930ex311.htm EX-31.1 11235
3 EXHIBIT 31.2 sls20180930ex312.htm EX-31.2 11262
4 EXHIBIT 32.1 sls20180930ex321.htm EX-32.1 18203
11 sellas-logoa05.jpg GRAPHIC 30719
  Complete submission text file 0001390478-18-000035.txt   5564276

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gale-20180930.xml EX-101.INS 999526
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20180930.xsd EX-101.SCH 53235
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20180930_cal.xml EX-101.CAL 67147
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20180930_def.xml EX-101.DEF 262439
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20180930_lab.xml EX-101.LAB 630349
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20180930_pre.xml EX-101.PRE 391856
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 181184621
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1